Analyst Reco. Healthcare Realty Trust Incorporated

Equities

HR

US42226K1051

End-of-day quote Nyse Other stock markets 18:00:00 2024-05-01 EDT			5-day change	1st Jan Change
14.56 ^USD	+0.34%		+2.97%	-15.50%

05-01	Healthcare Realty Trust Maintains Dividend at $0.31 per Share, Payable on May 23 to Shareholders of Record on May 13	MT
04-30	Healthcare Realty Trust Incorporated Announces its Common Stock Cash Dividend, Payable on May 23, 2024 to Class A Common Stockholders	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Citigroup Cuts Healthcare Realty Trust Price Target to $13 From $17.50, Maintains Neutral Rating	03-19	MT
JPMorgan Cuts Price Target on Healthcare Realty Trust to $17 From $19, Maintains Overweight Rating	03-06	MT
Stifel Downgrades Healthcare Realty Trust to Hold Form Buy, Price Target is $15	02-20	MT
Wedbush Downgrades Healthcare Realty Trust to Neutral From Outperform, Says Up Against Elevated Investor Scrutiny With Slim Margin for Error in Near-Term; Adjusts PT to $15 From $19	02-20	MT
Deutsche Bank Initiates Coverage on Healthcare Realty Trust With Hold Rating, $18 Price Target	01-30	MT
Wells Fargo Trims Price Target on Healthcare Realty Trust to $16 From $17, Maintains Equalweight Rating	11-13	MT
BTIG Upgrades Healthcare Realty Trust to Buy From Neutral, Price Target is $17	23-10-24	MT
JPMorgan Upgrades Healthcare Realty Trust to Overweight From Neutral, Price Target is $19	23-10-12	MT
Scotiabank Cuts Healthcare Realty Trust's Price Target to $17 From $19, Maintains Sector Perform Rating	23-10-10	MT
Wells Fargo Adjusts Healthcare Realty Trust's Price Target to $17 From $19, Equalweight Rating Kept	23-10-10	MT
BMO Capital Cuts Price Target on Healthcare Realty Trust to $17 From $20, Keeps Market Perform Rating	23-10-06	MT
Wedbush Starts Healthcare Realty Trust at Outperform With $17 Price Target	23-10-03	MT
Citigroup Adjusts Price Target on Healthcare Realty Trust to $17 From $19, Maintains Neutral Rating	23-08-22	MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $24 From $25, Maintains Overweight Rating	23-08-11	MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $25 From $24, Keeps Overweight Rating	23-05-11	MT
Healthcare Realty Trust's First Q1 Normalized FFO Since Merger With Healthcare Trust of America Beats Analysts' Expectations	23-05-09	MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $24 From $28, Maintains Overweight Rating	23-03-29	MT
Credit Suisse Downgrades Healthcare Realty Trust to Neutral From Outperform, Lowers Price Target to $20 From $23	23-03-06	MT
Fitch Affirms Healthcare Realty Trust at 'BBB'; Outlook Stable	23-02-22	AQ
Citigroup Downgrades Healthcare Realty Trust to Neutral From Buy, Adjusts Price Target to $20 From $22.50	22-12-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Healthcare Realty Trust Incorporated

Equities

HR

US42226K1051

Analyst Reco.

Filters